Among the prognostic factors investigated, a DRFI > 24 months was independently associated with better OS in HER2-positive MBC regardless of HR status, suggesting that DRFI was closely related to the biological characteristics of both primary tumours and their metastases. This evidence concerns the gene ERBB2 and neoplasm.